This summary outlines recent health-related developments, including expansions in the bird flu vaccine supply, regulatory ...

Federal officials plan to double the stockpile of emergency bird flu vaccines as they identify more people infected with the ...

The companies will use the funds to fill vials and pre-filled syringes with stockpiled vaccine ingredients, aimed at raising ...

As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its ...

A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV ...

The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to ...

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...

California health officials yesterday announced the state's second H5N1 avian flu infection in a dairy farm worker who had no ...

There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...

First discovered in chimpanzees in 1956 and children the following year, respiratory syncytial virus (RSV), isn’t new.

Sanofi (SNY), and CSL (CSLLY) win $72M U.S. contract to expand bird flu vaccine production amid fears of human transmission.